Patents by Inventor Isabelle Mus-Veteau

Isabelle Mus-Veteau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Panicein compounds, compositions and uses thereof
    Patent number: 10376476
    Abstract: The present invention relates to the fields of medicine and cancer treatment. The invention more specifically relates to the use of a panicein or a derivative thereof, to decrease or inhibit, in vitro or ex vivo, the Patched receptor drug efflux activity, in particular the chemotherapeutic drug efflux activity and chemotherapy resistance. The present disclosure further relates to uses of such compounds, in particular to prepare a pharmaceutical composition to allow or improve the efficiency of a therapy of cancer in a subject in need thereof. The compound of the invention can indeed be advantageously used, in combination with at least one chemotherapeutic drug, for treating cancer, for preventing cancer metastasis and/or for preventing cancer recurrence in a subject.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: August 13, 2019
    Assignees: UNIVERSITE NICE SOPHIA ANTIPOLIS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Isabelle Mus-Veteau, Olivier Thomas, Marie-Aude Tribalat, Stephane Azoulay
  • PANICEIN COMPOUNDS, COMPOSITIONS AND USES THEREOF
    Publication number: 20180200200
    Abstract: The present invention relates to the fields of medicine and cancer treatment. The invention more specifically relates to the use of a panicein or a derivative thereof, to decrease or inhibit, in vitro or ex vivo, the Patched receptor drug efflux activity, in particular the chemotherapeutic drug efflux activity and chemotherapy resistance. The present disclosure further relates to uses of such compounds, in particular to prepare a pharmaceutical composition to allow or improve the efficiency of a therapy of cancer in a subject in need thereof. The compound of the invention can indeed be advantageously used, in combination with at least one chemotherapeutic drug, for treating cancer, for preventing cancer metastasis and/or for preventing cancer recurrence in a subject.
    Type: Application
    Filed: March 14, 2018
    Publication date: July 19, 2018
    Inventors: ISABELLE MUS-VETEAU, OLIVIER THOMAS, MARIE-AUDE TRIBALAT, STEPHANE AZOULAY
  • PANICEIN COMPOUNDS, COMPOSITIONS AND USES THEREOF
    Publication number: 20170326076
    Abstract: The present invention relates to the fields of medicine and cancer treatment. The invention more specifically relates to the use of a panicein or a derivative thereof, to decrease or inhibit, in vitro or ex vivo, the Patched receptor drug efflux activity, in particular the chemotherapeutic drug efflux activity and chemotherapy resistance. The present disclosure further relates to uses of such compounds, in particular to prepare a pharmaceutical composition to allow or improve the efficiency of a therapy of cancer in a subject in need thereof. The compound of the invention can indeed be advantageously used, in combination with at least one chemotherapeutic drug, for treating cancer, for preventing cancer metastasis and/or for preventing cancer recurrence in a subject.
    Type: Application
    Filed: October 26, 2015
    Publication date: November 16, 2017
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE NICE SOPHIA ANTIPOLIS
    Inventors: ISABELLE MUS-VETEAU, OLIVIER THOMAS, MARIE-AUDE TRIBALAT, STÉPHANE AZOULAY
  • NOVEL THERAPEUTIC STRATEGIES FOR IMPROVING AN ANTICANCER TREATMENT
    Publication number: 20140011277
    Abstract: The subject of the invention is novel medicaments intended to modulate the intracellular concentration of anticancer agents through the modulation of the activity of Patched protein. The invention is used in particular in the improvement of the treatment of cancers.
    Type: Application
    Filed: December 9, 2011
    Publication date: January 9, 2014
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Isabelle Mus-Veteau, Michel Bidet